iPierian's Grant

iPierian raised a round of funding on October 09, 2009. Investors include National Institutes of Health.

iPierian is a biotechnology company developing therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against targets of the Tau protein for treatment of Al…

Articles about iPierian's Grant: